Reported Sep 13, 2023 · Completed
Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc,…
Esperion
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Esperion · 3891 Ranchero Dr Ste 150 · Ann Arbor, MI · 48108-2837
Is this the product you have?
- Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only
- Manufactured forEsperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03
- Lot codes and dates
Lot# 1904872Exp 1/31/20251950377Exp 6/30/2025
- Amount recalled
- 45,240 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed dissolution specifications: below specification results at stability 12-month
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Esperion recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.